MVZ Corius Potsdam GmbH

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atopic dermatitis (eczema)3 trials
• Psoriasis2 trials

Phase

• Phase 35 trials

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Almirall S.A.1 trial
• Incyte Corporation1 trial
• Janssen - Cilag International1 trial
• Janssen-Cilag International NV1 trial
• LEO Pharma1 trial

Running trials

• Recruiting

  A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

  NCT06311682· Phase 3· LEO Pharma· Source

• Recruiting

  A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

  2023-505121-14-00· Phase 3· Janssen - Cilag International· Source

Closed trials

• Completed

  A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis

  NCT06238817· Phase 3· Incyte Corporation· Source

• Completed

  A Phase 3b, Open-label Study to Evaluate the Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

  2023-505558-16-00· Phase 3· Almirall S.A.· Source

• Completed

  A Study to Evaluate Further Therapeutic Strategies With Guselkumab in Participants With Moderate-to-Severe Plaque-Type Psoriasis

  NCT03818035· Phase 3· Janssen-Cilag International NV· Source